Home » Newsletters » BioWorld Science

BioWorld Science

April 3, 2020

View Archived Issues

Females, males have different metabolic response to intermittent fasting

First patient dosed in phase I/IIa study of TJC-4 in China

Positive data from investigator-initiated trial of DAS-181 for the treatment of COVID-19

Topline phase Ib/IIa results for AB-2004 in patients with ASD

Update on phase II study of ifenprodil in patients with COVID-19

Leronlimab shows potential immunological restoration in severely ill COVID-19 patients

Novel bleomycin-induced cynomolgus monkey model of IPF

Serum indoxyl sulfate as independent biomarker of arterial stiffness in CAD

Serum EV-Tspan8 level predicts distant metastasis in NSCLC

Silverback Therapeutics discloses new benzazepine compounds

ERN1 inhibitors discovered at Genentech

British American Tobacco announces work on potential vaccine for COVID-19

Roche identifies antagonists of Toll-like receptors

Crinetics Pharmaceuticals presents somatostatin SST2 receptor agonists

Terns synthesizes new ABL1/ABL2/Bcr-Abl inhibitors

Researchers develop a mouse model of 3q.29 deletion-driven psychiatric disorder

GigaGen developing recombinant polyclonal antibody therapy rCIG for COVID-19

New protein tau tracer [18F]THK-5562 developed for diagnosing Alzheimer's disease

X, Y copies of neuroligin-4 have different functions

Incyte and Novartis plan phase III evaluation of Jakavi for COVID-19-associated cytokine storm

Researchers create rat model of AKI to CKD progression

Vanda begins phase III study of tradipitant in hospitalized patients with COVID-19 pneumonia

FDA clears IND for phase I/II study of NK cell therapy CYNK-001 for COVID-19

European Commission approves rituximab biosimilar Ruxience

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...